163 related articles for article (PubMed ID: 24383119)
21. Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials.
Pasceri V; Pelliccia F; Bressi E; Mantione L; Gaudio C; Speciale G; Mehran R; Dangas GD; Patti G
Int J Cardiol; 2018 Sep; 266():75-80. PubMed ID: 29887476
[TBL] [Abstract][Full Text] [Related]
22. The best DEFENSE for high-risk patent foramen ovale: An updated meta-analysis of six randomized trials.
Kokkinidis DG; Palaiodimos L; Mastoris I; Karamanis D; Faillace RT
Arch Cardiovasc Dis; 2019 Mar; 112(3):150-152. PubMed ID: 30594572
[No Abstract] [Full Text] [Related]
23. Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis.
Lattanzi S; Brigo F; Cagnetti C; Di Napoli M; Silvestrini M
Cerebrovasc Dis; 2018; 45(5-6):193-203. PubMed ID: 29649819
[TBL] [Abstract][Full Text] [Related]
24. Patent foramen ovale closure versus medical therapy in cases with cryptogenic stroke, meta-analysis of randomized controlled trials.
Abo-Salem E; Chaitman B; Helmy T; Boakye EA; Alkhawam H; Lim M
J Neurol; 2018 Mar; 265(3):578-585. PubMed ID: 29356972
[TBL] [Abstract][Full Text] [Related]
25. Cryptogenic Stroke and Patent Foramen Ovale.
Mojadidi MK; Zaman MO; Elgendy IY; Mahmoud AN; Patel NK; Agarwal N; Tobis JM; Meier B
J Am Coll Cardiol; 2018 Mar; 71(9):1035-1043. PubMed ID: 29495983
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous closure versus medical therapy for stroke with patent foramen Ovale: a systematic review and meta-analysis.
Zhang XL; Kang LN; Wang L; Xu B
BMC Cardiovasc Disord; 2018 Mar; 18(1):45. PubMed ID: 29499641
[TBL] [Abstract][Full Text] [Related]
27. Closure of patent foramen ovale and "cryptogenic" stroke: What's new, what's next?
Mas JL
Arch Cardiovasc Dis; 2019 Mar; 112(3):145-149. PubMed ID: 30792077
[No Abstract] [Full Text] [Related]
28. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
Carroll JD; Saver JL; Thaler DE; Smalling RW; Berry S; MacDonald LA; Marks DS; Tirschwell DL;
N Engl J Med; 2013 Mar; 368(12):1092-100. PubMed ID: 23514286
[TBL] [Abstract][Full Text] [Related]
29. Patent Foramen Ovale Closure: The Pendulum Swings.
Hankey GJ; McQuillan BM
Circulation; 2018 May; 137(19):1991-1993. PubMed ID: 29735585
[No Abstract] [Full Text] [Related]
30. Transcatheter Patent Foramen Ovale Closure After Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Trials.
Mojadidi MK; Elgendy AY; Elgendy IY; Mahmoud AN; Elbadawi A; Eshtehardi P; Patel NK; Wayangankar S; Tobis JM; Meier B
JACC Cardiovasc Interv; 2017 Nov; 10(21):2228-2230. PubMed ID: 29122137
[No Abstract] [Full Text] [Related]
31. Prevention of stroke in patients with patent foramen ovale.
Mattle HP; Meier B; Nedeltchev K
Int J Stroke; 2010 Apr; 5(2):92-102. PubMed ID: 20446943
[TBL] [Abstract][Full Text] [Related]
32. Recurrent events after percutaneous closure of patent foramen ovale.
Wallenborn J; Bertog SC; Franke J; Steinberg DH; Majunke N; Wilson N; Wunderlich N; Sievert H
Catheter Cardiovasc Interv; 2013 Oct; 82(4):541-6. PubMed ID: 22707325
[TBL] [Abstract][Full Text] [Related]
33. Closure versus Medical Therapy for Patent Foramen Ovale in Patients with Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Controlled Trials.
Qiu B; Cai Y; Wang D; Lin J; Fan Y
J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3463-3472. PubMed ID: 30185398
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
[TBL] [Abstract][Full Text] [Related]
35. Multidisciplinary Assessment in Optimising Results of Percutaneous Patent Foramen Ovale Closure.
Davies A; Ekmejian A; Collins N; Bhagwandeen R
Heart Lung Circ; 2017 Mar; 26(3):246-250. PubMed ID: 27555053
[TBL] [Abstract][Full Text] [Related]
36. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials.
Kwong JS; Lam YY; Yu CM
Int J Cardiol; 2013 Oct; 168(4):4132-8. PubMed ID: 23890879
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: Comprehensive systematic review and meta-analysis of randomized controlled trials.
Hakeem A; Marmagkiolis K; Hacioglu Y; Uretsky BF; Gundogdu B; Leesar M; Bailey SR; Cilingiroglu M
Cardiovasc Revasc Med; 2013; 14(6):349-55. PubMed ID: 24080379
[TBL] [Abstract][Full Text] [Related]
39. Patent foramen ovale and ischemic stroke recurrence: the end of a never-ending story?
Tamayo A; Harrer JU
Neurology; 2009 Jul; 73(2):84-5. PubMed ID: 19439718
[No Abstract] [Full Text] [Related]
40. Patent foramen ovale closure to prevent secondary neurologic events.
Jasper R; Blankenship JC
Eur J Intern Med; 2017 Oct; 44():1-11. PubMed ID: 28684051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
